手法を比較
選択した手法を並べて確認できます。異なる行はハイライト表示されます。
| 閉経期症状評価尺度（MRS）× | Female Sexual Function Index (FSFI)× | |
|---|---|---|
| 分野 | 泌尿器・婦人科学 | 泌尿器・婦人科学 |
| 系統 | Process / pipeline | Process / pipeline |
| 提唱年 | 2000 | 2000 |
| 提唱者≠ | Heinemann et al. | Rosen et al. |
| 種類≠ | Self-report symptom scale | Self-report questionnaire |
| 原典≠ | Heinemann, K., Assmann, A., Möhner, S., & Schneider, H. P. (2004). The Menopause Rating Scale (MRS) as outcome measure for hormone replacement therapy. Menopause, 11(5), 571–578. DOI ↗ | Rosen, R., Brown, C., Heiman, J., Leiblum, S., Meston, C., Shabsigh, R., & D'Agostino, R. (2000). The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. Journal of Sex & Marital Therapy, 26(2), 191–208. DOI ↗ |
| 別名 | MRS | FSFI |
| 関連≠ | 3 | 4 |
| 概要≠ | The MRS is an 11-item self-report symptom scale designed to assess the frequency and severity of menopausal symptoms including vasomotor complaints, psychologic symptoms, and urogenital manifestations. Developed by Heinemann and colleagues in Germany and first published in 2000, it has become the most widely used symptom measure in menopause research and clinical practice across 60+ countries and languages. | The FSFI is a 19-item multidimensional self-report instrument designed to assess sexual function in women across the lifespan. Developed by Rosen and colleagues in 2000, it measures six core domains of sexual response and has become a gold standard in both clinical and research settings for evaluating female sexual dysfunction. |
| ScholarGateデータセット ↗ |
|
|